Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Aug 5, 2024, after the close
10-Q filed Aug 5, 2024, 36 days after period end · 0000950170-24-090905
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $49.86M | $10.52M | $27.09M | $2.00M |
| Net Income | -$17.22M | -$52.55M | -$21.56M | -$54.58M |
| EPS Diluted |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
| -$0.64 |
| -$1.98 |
| -$0.82 |
| -$2.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.